Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?
In a disclosure of its holdings, Joseph Edelman's Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) last week...
Posts Tagged ‘Joseph Edelman Perceptive Advisors’
Is Conceptus, Inc. (CPTS) Going to Burn These Hedge Funds?
To the average investor, there are plenty of gauges investors can use to watch publicly traded companies.
This Metric Says You Are Smart to Buy ISIS Pharmaceuticals, Inc. (ISIS)
Is ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) worth your attention right now? Investors who are in the know are taking an optimistic view.
Regeneron Pharmaceuticals Inc (REGN): Are Hedge Funds Right About This Stock?
To the average investor, there are dozens of indicators market participants can use to analyze the equity markets.
Is Viropharma Inc (VPHM) Going to Burn These Hedge Funds?
Viropharma Inc (NASDAQ:VPHM) was in 16 hedge funds' portfolio at the end of March. VPHM has seen a decrease in activity from the world's largest hedge funds in recent months.
Hedge Funds Are Betting On Aegerion Pharmaceuticals, Inc. (AEGR)
In the eyes of most market participants, hedge funds are assumed to be slow, old investment tools of yesteryear.
Here is What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of March.
Hedge Funds Are Crazy About Aegerion Pharmaceuticals, Inc. (AEGR)
According to most market participants, hedge funds are assumed to be underperforming, outdated financial tools of the past.
AcelRx Pharmaceuticals Inc (ACRX): Hedge Funds and Insiders Are Bullish, What Should You Do?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) the right investment to pursue these days? Investors who are in the know are in an optimistic mood.
Hedge Fund News: Warren Buffett, Steve Cohen, Sprint Nextel Corporation (S)
Editor's Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc.
Infinity Pharmaceuticals Inc. (INFI): Billionaire Steve Cohen’ SAC Up to 5% of This Stock
According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals Inc.
Hedge Funds Are Buying Uroplasty, Inc. (UPI)
Is Uroplasty, Inc. (NASDAQ:UPI) an excellent investment now? The smart money is taking an optimistic view.
This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT): Acorda Therapeutics Inc (ACOR), Nektar Therapeutics (NKTR)
According to most traders, hedge funds are perceived as underperforming, old investment tools of yesteryear.
Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds' portfolio at the end of December.
Do Hedge Funds and Insiders Love Novartis AG (ADR) (NYSE:NVS)?
At the moment, there are tons of gauges market participants can use to track the equity markets. A duo of the best are hedge fund and insider trading sentiment.
